MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease-Reference-Cited by-同舟云学术

MicroRNA-224 Negatively Regulates p21 Expression During Late Neoplastic Progression in Inflammatory Bowel Disease

Published:2013-03 Issue:3 Volume:19 Page:471-480
ISSN:1078-0998
Container-title:Inflammatory Bowel Diseases
language:en
Short-container-title:Inflammatory Bowel Diseases

Author:

Olaru Alexandru V.,Yamanaka Sumitaka,Vazquez Christine,Mori Yuriko,Cheng Yulan,Abraham John M.,Bayless Theodore M.,Harpaz Noam,Selaru Florin M.,Meltzer Stephen J.

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,Immunology and Allergy

Reference44 articles.

1. Cancer risk in patients with inflammatory bowel disease

2. Review article: the incidence and prevalence of colorectal cancer in inflammatory bowel disease

3. Ulcerative Colitis and Colorectal Cancer

4. Colorectal carcinoma in inflammatory bowel disease: a comparison between Crohn’s and ulcerative colitis

Cited by 53 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The miRNA Landscape in Crohn's disease: Implications for novel therapeutic approaches and interactions with Existing therapies;Experimental Cell Research;2024-10

2. Cross-Kingdom Interaction of miRNAs and Gut Microbiota with Non-Invasive Diagnostic and Therapeutic Implications in Colorectal Cancer;International Journal of Molecular Sciences;2023-06-23

3. Non‐coding RNAs and colitis‐associated cancer: Mechanisms and clinical applications;Clinical and Translational Medicine;2023-05

4. Protective effect of five-flavor sophora flavescens enteric-coated capsules on inflammatory bowel disease and its molecular mechanism;Food Science and Technology;2023

5. Cancer Immunotherapy: The Checkpoint between Chronic Colitis and Colorectal Cancer;Cancers;2022-12-12